These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
820 related articles for article (PubMed ID: 12210292)
1. HFE based re-evaluation of heterozygous hemochromatosis. Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292 [TBL] [Abstract][Full Text] [Related]
2. [Molecular genetic diagnostics and screening of hereditary hemochromatosis]. Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764 [TBL] [Abstract][Full Text] [Related]
3. HFE mutations, iron deficiency and overload in 10,500 blood donors. Jackson HA; Carter K; Darke C; Guttridge MG; Ravine D; Hutton RD; Napier JA; Worwood M Br J Haematol; 2001 Aug; 114(2):474-84. PubMed ID: 11529872 [TBL] [Abstract][Full Text] [Related]
4. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes. Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375 [TBL] [Abstract][Full Text] [Related]
5. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis. Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080 [TBL] [Abstract][Full Text] [Related]
6. Hemochromatosis and iron-overload screening in a racially diverse population. Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P; N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186 [TBL] [Abstract][Full Text] [Related]
8. Iron absorption by heterozygous carriers of the HFE C282Y mutation associated with hemochromatosis. Hunt JR; Zeng H Am J Clin Nutr; 2004 Oct; 80(4):924-31. PubMed ID: 15447900 [TBL] [Abstract][Full Text] [Related]
9. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis. Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390 [TBL] [Abstract][Full Text] [Related]
10. Analysis of HLA-A antigens and C282Y and H63D mutations of the HFE gene in Brazilian patients with hemochromatosis. Bittencourt PL; Palácios SA; Couto CA; Cançado EL; Carrilho FJ; Laudanna AA; Kalil J; Gayotto LC; Goldberg AC Braz J Med Biol Res; 2002 Mar; 35(3):329-35. PubMed ID: 11887210 [TBL] [Abstract][Full Text] [Related]
11. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases. Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475 [TBL] [Abstract][Full Text] [Related]
12. Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy. Cassanelli S; Pignatti E; Montosi G; Garuti C; Mariano M; Campioli D; Carbonieri A; Baldini E; Pietrangelo A J Hepatol; 2001 Apr; 34(4):523-8. PubMed ID: 11394651 [TBL] [Abstract][Full Text] [Related]
13. Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosis. Lawless MW; White M; Mankan AK; O'Dwyer MJ; Norris S Tissue Antigens; 2007 Oct; 70(4):294-300. PubMed ID: 17767550 [TBL] [Abstract][Full Text] [Related]
14. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study. Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565 [TBL] [Abstract][Full Text] [Related]
15. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives. Moirand R; Jouanolle AM; Brissot P; Le Gall JY; David V; Deugnier Y Gastroenterology; 1999 Feb; 116(2):372-7. PubMed ID: 9922318 [TBL] [Abstract][Full Text] [Related]
16. Testing for haemochromatosis in a liver clinic population: relationship between ethnic origin, HFE gene mutations, liver histology and serum iron markers. Moodie SJ; Ang L; Stenner JM; Finlayson C; Khotari A; Levin GE; Maxwell JD Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):223-9. PubMed ID: 11953685 [TBL] [Abstract][Full Text] [Related]
18. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gochee PA; Powell LW; Cullen DJ; Du Sart D; Rossi E; Olynyk JK Gastroenterology; 2002 Mar; 122(3):646-51. PubMed ID: 11874997 [TBL] [Abstract][Full Text] [Related]
19. A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote. Wallace DF; Dooley JS; Walker AP Gastroenterology; 1999 Jun; 116(6):1409-12. PubMed ID: 10348824 [TBL] [Abstract][Full Text] [Related]
20. Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women. Rossi E; Olynyk JK; Cullen DJ; Papadopoulos G; Bulsara M; Summerville L; Powell LW Clin Chem; 2000 Feb; 46(2):162-6. PubMed ID: 10657371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]